Philadelphia Trust Company’s GoodRx Holdings GDRX Stock Holding History

Philadelphia Trust Company’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-261,381	Closed	-$5.05M	–	226
2022 Q1	$5.05M	Sell	261,381 -25,692	-9%	-$589K	0.4%	59
2021 Q4	$9.38M	Buy	287,073 +27,912	+11%	+$1.12M	0.68%	41
2021 Q3	$10.6M	Buy	259,161 +202,074	+354%	+$7.33M	0.78%	39
2021 Q2	$2.06M	Sell	57,087 -33,979	-37%	-$1.25M	0.14%	101
2021 Q1	$3.55M	Buy	+91,066	New	+$4.1M	0.27%	73

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Philadelphia Trust Company's GDRX Position: Q2 2022 in Review

Philadelphia Trust Company sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 261,381 shares — an estimated $5.05M sold.

Philadelphia Trust Company first reported a position in GDRX in Q1 2021 and held it in 5 quarters. The position peaked at $10.6M in Q3 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

Philadelphia Trust Company reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
Philadelphia Trust Company sold 261,381 GoodRx Holdings shares in Q2 2022, an estimated $5.05M.
Philadelphia Trust Company first reported a position in GoodRx Holdings in Q1 2021 and held it in 5 quarters.
Philadelphia Trust Company's GoodRx Holdings position peaked at $10.6M in Q3 2021.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Philadelphia Trust Company's 13F filing for Q2 2022, filed 15 Aug 2022.